Comparative immunogenicity of recombinant influenza hemagglutinin (rHA) and trivalent inactivated vaccine (TIV) among persons ≥65 years old
- 1 December 2009
- journal article
- research article
- Published by Elsevier BV in Vaccine
- Vol. 28 (2), 379-385
- https://doi.org/10.1016/j.vaccine.2009.10.037
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Mortality benefits of influenza vaccination in elderly people: an ongoing controversyThe Lancet Infectious Diseases, 2007
- Impact of Influenza Vaccination on Seasonal Mortality in the US Elderly PopulationArchives of Internal Medicine, 2005
- Influenza-Associated Hospitalizations in the United StatesJAMA, 2004
- Influenza Vaccination and Reduction in Hospitalizations for Cardiac Disease and Stroke among the ElderlyNew England Journal of Medicine, 2003
- A meta-analysis of effectiveness of influenza vaccine in persons aged 65 years and over living in the communityVaccine, 2002
- The Efficacy of Influenza Vaccination in Elderly IndividualsJAMA, 1994
- Excess pneumonia and influenza associated hospitalization during influenza epidemics in the United States, 1970-78.American Journal of Public Health, 1986
- Efficacy of Influenza Vaccine in Nursing HomesJAMA, 1985
- Influenza Vaccination of Elderly PersonsPublished by American Medical Association (AMA) ,1980
- Interpandemic Influenza in the Houston Area, 1974–76New England Journal of Medicine, 1978